Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Antibiotics Deconstructed
Clinical Forum Insights

Subscribe

  • News
  • Watch
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Antibiotics Deconstructed|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

Joseph M. Collaco, MD, PhD

Advertisement

Articles by Joseph M. Collaco, MD, PhD

RSV Prophylaxis: Palivizumab, Nirsevimab, and More

By Noah Christian, MD,Joseph M. Collaco, MD, PhD
May 9th 2025

Current prevention strategies include two injectables for infants and young children, namely palivizumab and nirsevimab.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Contagion Live

    1

    Washington State Reports First US Avian Influenza Death of 2026

    2

    Nearly 30% of US Adults Report Misrepresenting Symptoms to Get Antibiotics

    3

    FDA Tentatively Approves First Generic Lenacapavir PrEP for 120 LMICs

    4

    FDA Approves Voceryq, First Plasmid DNA Immunotherapy for Recurrent Respiratory Papillomatosis

    5

    Postapproval Surveillance Confirms Ceftobiprole Activity Against MRSA

    • About Us
    • Advertise
    • Editorial
    • Contact Us
    • Do Not Sell My Information
    • Privacy
    • Terms & Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    • Contagion Live
    • CGT Live
    • Neurology Live
    • HCP Live
    • Oncology Live
    • Contemporary Pediatrics
    • Contemporary OBGYN
    • Urology Times
    • The Educated Patient
    • Patient Care Online
    HCP Live Network
    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us